NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Mutual Fund Legend Peter Lynch's Success Story

Fidelity's Magellan Fund, one of the most iconic mutual funds in US history, achieved remarkable success under the leadership of Peter Lynch, who managed the fund from 1977 to 1990. During his tenure, the fund delivered a 29.2% Compound Annual Growth Rate (CAGR), far exceeding the performance of the S&P 500 benchmark.

Under Lynch's guidance, the fund's assets grew significantly, increasing from a modest $18 million in 1977 to an impressive $14 billion by the time he retired at 46. This remarkable growth trajectory solidifies Lynch's reputation as one of the most successful mutual fund managers in US history.

Read also: Groww AMC Secures Strategic Boost as SEBI Approves State Street Global Advisors' Minority Stake

Investor Takeaway

Investors can learn from Peter Lynch's successful stock picking strategies to inform their own investment decisions.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.